Report Content
Chapter 1 Methodology & Scope
1.1 Market definition & scope
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global ursodeoxycholic acid industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Type trends
2.1.4 Application trends
2.1.5 Mode trends
2.1.6 Use trends
Chapter 3 Ursodeoxycholic Acid Industry Insights
3.1 Industry ecosystem
3.2 COVID-19 impact analysis
3.3 Regulatory landscape
3.3.1 U.S.
3.3.2 Europe
3.4 Pricing analysis, by region
3.4.1 Selling price in USD per kg
3.5 Innovation & sustainability
3.6 Industry impact forces
3.6.1 Growth drivers
3.6.1.1 Rising prevalence of liver diseases and gallstones
3.6.1.2 Growing pharmaceutical industry
3.6.1.3 Increasing research and development related to ursodeoxycholic acid
3.6.2 Industry pitfalls & challenges
3.6.2.1 Side effects of Ursodeoxycholic acid
3.7 Growth potential analysis
3.7.1 By type
3.7.2 By application
3.7.3 By mode
3.7.4 By use
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 ICE s.p.a.
4.1.2 Merck KGaA
4.1.3 Daewoong Bio
4.2 Competitive positioning matrix, 2022
4.3 Strategic outlook matrix
4.4 Company share analysis, 2022
4.4.1 Global
4.4.2 North America
4.4.3 Europe
4.4.4 Asia Pacific
4.5 Production capacity
4.6 List of top 20 end consumers with contact details/email id
Chapter 5 Ursodeoxycholic Acid Market, By Service Type, 2018 - 2032 (USD Million)
5.1 Key trends, by type
5.2 Synthetic ursodeoxycholic acid
5.3 Biological ursodeoxycholic acid
Chapter 6 Ursodeoxycholic Acid Market, By Application, 2018 – 2032 (USD Million)
6.1 Key trends, by application
6.2 Primary biliary cholangitis
6.3 Gallstones
6.4 Other applications
Chapter 7 Ursodeoxycholic Acid Market, By Mode, 2018 – 2032 (USD Million)
7.1 Key trends, by mode
7.2 In-house manufacturing
7.3 Contract manufacturing
Chapter 8 Ursodeoxycholic Acid Market, By Use, 2018 – 2032 (USD Million)
8.1 Key trends, by use
8.2 Human
8.3 Veterinary
Chapter 9 Ursodeoxycholic Acid Market, By Region, 2018 – 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 France
9.3.2 Italy
9.3.3 Germany
9.3.4 UK
9.3.5 Russia
9.3.6 Spain
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 Malaysia
9.4.7 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of MEA
Chapter 10 Company Profiles
10.1 Merck KGaA
10.2 Changde Yungang Biotechnology Co. Ltd.
10.3 Daewoong Bio
10.4 Osmopharm SA
10.5 ICE s.p.a
10.6 Dipharma Francis S.r.l.
10.7 Tianjin NWS Biotechnology and Medicine Co. Ltd
10.8 Zhongshan Belling Biotechnology Co. Ltd.
10.9 Axplora
10.10 Anant Pharmaceuticals Pvt Ltd
10.11 IOL Chemicals and Pharmaceuticals
10.12 Glenmark Pharmaceuticals
10.13 Cerata Pharmaceuticals
10.14 Kimia Biosciences Ltd
